AXSM
NASDAQStockAxsome Therapeutics, Inc.
$154.97-4.59 (-2.88%)
52-Week Range
$95.65
$189.10
Key Stats
Market Cap
7.9B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.49
Volume
584.9K
Avg Volume
594.8K
Performance
1M
-13.46%
3M
+7.65%
6M
+36.59%
YTD
-10.74%
1Y
+33.53%
3Y
+162.08%
5Y
+144.56%
Price Chart
ETF Exposure
AXSM is held by 92 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| VHT | Vanguard Health Care ETF | 0.10% |
| VXF | Vanguard Extended Market ETF | 0.10% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.09% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.09% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.08% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.05% |
| WSML | iShares MSCI World Small-Cap ETF | 0.05% |
| SMMD | iShares Russell 2500 ETF | 0.05% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.04% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.04% |
| AVIE | Avantis Inflation Focused Equity ETF | 0.03% |
| HDG | ProShares - Hedge Replication ETF | 0.03% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.02% |
| BALI | iShares U.S. Large Cap Premium Income Active ETF | 0.02% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| ESGV | Vanguard ESG U.S. Stock ETF | 0.01% |
| VTI | Vanguard Total Stock Market ETF | 0.01% |
| IALT | iShares Systematic Alternatives Active ETF | 0.01% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.01% |
| IWV | iShares Russell 3000 ETF | 0.01% |
| SCHB | Schwab U.S. Broad Market ETF | 0.01% |
| SCHK | Schwab 1000 Index ETF | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | 0.01% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.01% |
| V3AL.L | Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% |
| VT | Vanguard Total World Stock ETF | 0.01% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
| EAOR | iShares ESG Aware 60/40 Balanced Allocation ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| AVTM | Avantis Total Equity Markets ETF 1 | 0.00% |
| EAOK | iShares ESG Aware 30/70 Conservative Allocation ETF | 0.00% |
| EAOM | iShares ESG Aware 40/60 Moderate Allocation ETF | 0.00% |
| GTPE | Goldman Sachs MSCI World Private Equity Return Tracker ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
PreviousPage 2 of 2
About AXSM ETF Exposure
Axsome Therapeutics, Inc. (AXSM) is held by 92 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 7.9B, AXSM is a widely held institutional stock. The stock currently trades at $154.97. Investors can gain exposure to AXSM through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AXSM, sorted by portfolio weight.